English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Eliciting broadly reactive neutralizing antibodies remains a challenge in HIV-1 vaccine development, complicated by variations in envelope (Env) subtype and structure, and by the assays used for product down-selection. Since a majority of new HIV-1 infections are subtype C and considering the novel properties of C Envs, a C Env (CO6980v0c22) from an acutely infected Tanzanian was developed as a candidate HIV vaccine.

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development